View in EDS HTML Full Text PDF Full Text

Inflammation PET and plasma neurofilament light predict survival in people with progressive supranuclear palsy.

Saved in:
Bibliographic Details
Title: Inflammation PET and plasma neurofilament light predict survival in people with progressive supranuclear palsy.
Authors: Shapiro NL; Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK.; UK Dementia Research Institute at the University of Cambridge, Cambridge, CB2 0AH, UK., Jones PS; Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK., Mak E; Department of Psychiatry, School of Clinical Medicine, Addenbrooke's Hospital, University of Cambridge, Cambridge, CB2 0SZ, UK., Tsvetanov KA; Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK.; Department of Psychology, University of Cambridge, Cambridge, CB2 3EB, UK., Goddard J; Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK.; UK Dementia Research Institute at the University of Cambridge, Cambridge, CB2 0AH, UK., Vontobel DS; Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK.; UK Dementia Research Institute at the University of Cambridge, Cambridge, CB2 0AH, UK., Durcan R; Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK., Chouliaras L; Department of Psychiatry, School of Clinical Medicine, Addenbrooke's Hospital, University of Cambridge, Cambridge, CB2 0SZ, UK., Fryer T; Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK.; Wolfson Brain Imaging Centre, University of Cambridge, Cambridge, CB2 0QQ, UK., Hong YT; Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK.; Wolfson Brain Imaging Centre, University of Cambridge, Cambridge, CB2 0QQ, UK., Aigbirhio F; Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK.; Wolfson Brain Imaging Centre, University of Cambridge, Cambridge, CB2 0QQ, UK., Heslegrave A; UK Dementia Research Institute and Department of Neurodegenerative Disease at UCL, London, NW1 3BT, UK., Franzmeier N; Munich Cluster for Systems Neurology (SyNergy), Munich, 81377, Germany.; Institute for Stroke and Dementia Research (iSD), University Hospital, Ludwig-Maximilians-Universität, Munich, 81377, Germany.; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, Mölndal, 431 39, Sweden., Brendel M; Munich Cluster for Systems Neurology (SyNergy), Munich, 81377, Germany.; Institute for Stroke and Dementia Research (iSD), University Hospital, Ludwig-Maximilians-Universität, Munich, 81377, Germany.; Bavarian Cancer Research Center (BZKF), Partner Site Munich, Munich, 80539, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, a partnership between German Cancer Research Center (DKFZ) and LMU Munich, Munich, 80366, Germany.; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich 81377, Germany.; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, 81377, Germany., Zetterberg H; UK Dementia Research Institute and Department of Neurodegenerative Disease at UCL, London, NW1 3BT, UK.; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, Mölndal, 431 39, Sweden.; Department of Neurodegenerative Disease, Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, 405 30, Sweden.; Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53792, USA.; Hong Kong Center for Neurodegenerative Diseases, Clear Water Bay, Hong Kong, China., O'Brien JT; Department of Psychiatry, School of Clinical Medicine, Addenbrooke's Hospital, University of Cambridge, Cambridge, CB2 0SZ, UK., Rowe JB; Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK.; Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, UK.; Medical Research Council Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, CB2 7EF, UK., Malpetti M; Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK.; UK Dementia Research Institute at the University of Cambridge, Cambridge, CB2 0AH, UK.; Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, UK.
Source: Brain communications [Brain Commun] 2025 Nov 27; Vol. 7 (6), pp. fcaf467. Date of Electronic Publication: 2025 Nov 27 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 101755125 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-1297 (Electronic) Linking ISSN: 26321297 NLM ISO Abbreviation: Brain Commun Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41416250
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Inflammation PET and plasma neurofilament light predict survival in people with progressive supranuclear palsy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Shapiro+NL%22">Shapiro NL</searchLink>; Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK.; UK Dementia Research Institute at the University of Cambridge, Cambridge, CB2 0AH, UK.<br /><searchLink fieldCode="AU" term="%22Jones+PS%22">Jones PS</searchLink>; Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK.<br /><searchLink fieldCode="AU" term="%22Mak+E%22">Mak E</searchLink>; Department of Psychiatry, School of Clinical Medicine, Addenbrooke's Hospital, University of Cambridge, Cambridge, CB2 0SZ, UK.<br /><searchLink fieldCode="AU" term="%22Tsvetanov+KA%22">Tsvetanov KA</searchLink>; Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK.; Department of Psychology, University of Cambridge, Cambridge, CB2 3EB, UK.<br /><searchLink fieldCode="AU" term="%22Goddard+J%22">Goddard J</searchLink>; Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK.; UK Dementia Research Institute at the University of Cambridge, Cambridge, CB2 0AH, UK.<br /><searchLink fieldCode="AU" term="%22Vontobel+DS%22">Vontobel DS</searchLink>; Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK.; UK Dementia Research Institute at the University of Cambridge, Cambridge, CB2 0AH, UK.<br /><searchLink fieldCode="AU" term="%22Durcan+R%22">Durcan R</searchLink>; Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK.<br /><searchLink fieldCode="AU" term="%22Chouliaras+L%22">Chouliaras L</searchLink>; Department of Psychiatry, School of Clinical Medicine, Addenbrooke's Hospital, University of Cambridge, Cambridge, CB2 0SZ, UK.<br /><searchLink fieldCode="AU" term="%22Fryer+T%22">Fryer T</searchLink>; Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK.; Wolfson Brain Imaging Centre, University of Cambridge, Cambridge, CB2 0QQ, UK.<br /><searchLink fieldCode="AU" term="%22Hong+YT%22">Hong YT</searchLink>; Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK.; Wolfson Brain Imaging Centre, University of Cambridge, Cambridge, CB2 0QQ, UK.<br /><searchLink fieldCode="AU" term="%22Aigbirhio+F%22">Aigbirhio F</searchLink>; Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK.; Wolfson Brain Imaging Centre, University of Cambridge, Cambridge, CB2 0QQ, UK.<br /><searchLink fieldCode="AU" term="%22Heslegrave+A%22">Heslegrave A</searchLink>; UK Dementia Research Institute and Department of Neurodegenerative Disease at UCL, London, NW1 3BT, UK.<br /><searchLink fieldCode="AU" term="%22Franzmeier+N%22">Franzmeier N</searchLink>; Munich Cluster for Systems Neurology (SyNergy), Munich, 81377, Germany.; Institute for Stroke and Dementia Research (iSD), University Hospital, Ludwig-Maximilians-Universität, Munich, 81377, Germany.; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, Mölndal, 431 39, Sweden.<br /><searchLink fieldCode="AU" term="%22Brendel+M%22">Brendel M</searchLink>; Munich Cluster for Systems Neurology (SyNergy), Munich, 81377, Germany.; Institute for Stroke and Dementia Research (iSD), University Hospital, Ludwig-Maximilians-Universität, Munich, 81377, Germany.; Bavarian Cancer Research Center (BZKF), Partner Site Munich, Munich, 80539, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, a partnership between German Cancer Research Center (DKFZ) and LMU Munich, Munich, 80366, Germany.; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich 81377, Germany.; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, 81377, Germany.<br /><searchLink fieldCode="AU" term="%22Zetterberg+H%22">Zetterberg H</searchLink>; UK Dementia Research Institute and Department of Neurodegenerative Disease at UCL, London, NW1 3BT, UK.; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, Mölndal, 431 39, Sweden.; Department of Neurodegenerative Disease, Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, 405 30, Sweden.; Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53792, USA.; Hong Kong Center for Neurodegenerative Diseases, Clear Water Bay, Hong Kong, China.<br /><searchLink fieldCode="AU" term="%22O'Brien+JT%22">O'Brien JT</searchLink>; Department of Psychiatry, School of Clinical Medicine, Addenbrooke's Hospital, University of Cambridge, Cambridge, CB2 0SZ, UK.<br /><searchLink fieldCode="AU" term="%22Rowe+JB%22">Rowe JB</searchLink>; Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK.; Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, UK.; Medical Research Council Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, CB2 7EF, UK.<br /><searchLink fieldCode="AU" term="%22Malpetti+M%22">Malpetti M</searchLink>; Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK.; UK Dementia Research Institute at the University of Cambridge, Cambridge, CB2 0AH, UK.; Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, UK.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101755125%22">Brain communications</searchLink> [Brain Commun] 2025 Nov 27; Vol. 7 (6), pp. fcaf467. <i>Date of Electronic Publication: </i>2025 Nov 27 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101755125 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2632-1297 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226321297%22">26321297 </searchLink><i>NLM ISO Abbreviation: </i>Brain Commun <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41416250
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/braincomms/fcaf467
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: fcaf467
    Titles:
      – TitleFull: Inflammation PET and plasma neurofilament light predict survival in people with progressive supranuclear palsy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Shapiro NL
      – PersonEntity:
          Name:
            NameFull: Jones PS
      – PersonEntity:
          Name:
            NameFull: Mak E
      – PersonEntity:
          Name:
            NameFull: Tsvetanov KA
      – PersonEntity:
          Name:
            NameFull: Goddard J
      – PersonEntity:
          Name:
            NameFull: Vontobel DS
      – PersonEntity:
          Name:
            NameFull: Durcan R
      – PersonEntity:
          Name:
            NameFull: Chouliaras L
      – PersonEntity:
          Name:
            NameFull: Fryer T
      – PersonEntity:
          Name:
            NameFull: Hong YT
      – PersonEntity:
          Name:
            NameFull: Aigbirhio F
      – PersonEntity:
          Name:
            NameFull: Heslegrave A
      – PersonEntity:
          Name:
            NameFull: Franzmeier N
      – PersonEntity:
          Name:
            NameFull: Brendel M
      – PersonEntity:
          Name:
            NameFull: Zetterberg H
      – PersonEntity:
          Name:
            NameFull: O'Brien JT
      – PersonEntity:
          Name:
            NameFull: Rowe JB
      – PersonEntity:
          Name:
            NameFull: Malpetti M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 27
              M: 11
              Text: 2025 Nov 27
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2632-1297
          Numbering:
            – Type: volume
              Value: 7
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Brain communications
              Type: main
ResultId 1